Announcement on Convening the 2025 Annual Performance Briefing
Filed with SSE · · 2 pages · Chinese
BrightGene Bio-Medical Technology Co. Ltd. on 6ix
Earlier from BrightGene Bio-Medical Technology
- 2025 Annual Report
- Announcement on Outward Investment and Related Party Transactions
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Voluntary Disclosure of the Proposed Selection of Partial Products in the National Continuation Drug Procurement
- Earnings Preannouncement for 2025
Later from BrightGene Bio-Medical Technology
- BrightGene Announces Positive Topline Phase 1 Results of Oral BGM0504 in Obesity in China and the United States
- Announcement on Resignation of the Directors and Senior Management Members
- Announcement on Adding Provisional Proposal at 2025 Annual General Meeting
- Announcement on Resolutions of the 2025 Annual General Meeting
- Indicative Announcement on ""Brightgene Convertible Bonds"" Expected to Meet Conditions for Redemption
Follow BrightGene Bio-Medical Technology into a list and get an email when it puts out news.
Follow BrightGene Bio-Medical Technology